| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | IkappaB kinase activity | 6.43e-08 | 3 | 81 | 3 | GO:0008384 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 7.36e-07 | 18 | 81 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 4.78e-06 | 28 | 81 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 9.54e-06 | 70 | 81 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.50e-05 | 37 | 81 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.19e-04 | 118 | 81 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | glycerol-3-phosphate O-acyltransferase activity | 1.61e-04 | 5 | 81 | 2 | GO:0004366 | |
| GeneOntologyMolecularFunction | transferrin receptor binding | 8.73e-04 | 11 | 81 | 2 | GO:1990459 | |
| GeneOntologyCellularComponent | dynein complex | 6.28e-05 | 54 | 83 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | transferase complex | RTF1 CCNE1 FBXO48 RGPD2 KMT2D KANSL1 RB1 IKBKE POLE DEPDC5 IKBKB FBXL5 CHUK | 1.03e-04 | 963 | 83 | 13 | GO:1990234 |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.30e-04 | 25 | 83 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | 3.73e-04 | 335 | 83 | 7 | GO:0061695 | |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 4.06e-04 | 157 | 83 | 5 | GO:1902554 | |
| GeneOntologyCellularComponent | IkappaB kinase complex | 4.29e-04 | 8 | 83 | 2 | GO:0008385 | |
| GeneOntologyCellularComponent | microtubule associated complex | 4.56e-04 | 161 | 83 | 5 | GO:0005875 | |
| GeneOntologyCellularComponent | protein kinase complex | 5.84e-04 | 170 | 83 | 5 | GO:1902911 | |
| GeneOntologyCellularComponent | inner dynein arm | 6.87e-04 | 10 | 83 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | CD40 receptor complex | 8.37e-04 | 11 | 83 | 2 | GO:0035631 | |
| GeneOntologyCellularComponent | microtubule | 1.25e-03 | 533 | 83 | 8 | GO:0005874 | |
| MousePheno | abnormal mammary gland physiology | 5.87e-06 | 88 | 72 | 6 | MP:0001881 | |
| MousePheno | abnormal apocrine gland physiology | 5.87e-06 | 88 | 72 | 6 | MP:0013555 | |
| MousePheno | abnormal lactation | 3.37e-05 | 72 | 72 | 5 | MP:0001882 | |
| Domain | IKKbetaNEMObind | 1.77e-05 | 2 | 79 | 2 | IPR022007 | |
| Domain | IKKbetaNEMObind | 1.77e-05 | 2 | 79 | 2 | PF12179 | |
| Domain | IKKbetaNEMObind | 1.77e-05 | 2 | 79 | 2 | SM01239 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.56e-05 | 14 | 79 | 3 | IPR024317 | |
| Domain | AAA_8 | 2.56e-05 | 14 | 79 | 3 | PF12780 | |
| Domain | DHC_fam | 3.19e-05 | 15 | 79 | 3 | IPR026983 | |
| Domain | Dynein_heavy_dom | 3.19e-05 | 15 | 79 | 3 | IPR004273 | |
| Domain | Dynein_heavy | 3.19e-05 | 15 | 79 | 3 | PF03028 | |
| Domain | VPS13 | 5.29e-05 | 3 | 79 | 2 | IPR026847 | |
| Domain | VPS13_mid_rpt | 5.29e-05 | 3 | 79 | 2 | PF16910 | |
| Domain | VPS13 | 5.29e-05 | 3 | 79 | 2 | PF16908 | |
| Domain | VPS13_N2 | 5.29e-05 | 3 | 79 | 2 | IPR031646 | |
| Domain | VPS13_mid_rpt | 5.29e-05 | 3 | 79 | 2 | IPR031642 | |
| Domain | VPS13_C | 1.05e-04 | 4 | 79 | 2 | PF16909 | |
| Domain | SHR-BD | 1.05e-04 | 4 | 79 | 2 | IPR009543 | |
| Domain | VPS13_C | 1.05e-04 | 4 | 79 | 2 | IPR031645 | |
| Domain | SHR-BD | 1.05e-04 | 4 | 79 | 2 | PF06650 | |
| Domain | SEC14 | 1.57e-04 | 25 | 79 | 3 | SM00516 | |
| Domain | CRAL_TRIO | 1.98e-04 | 27 | 79 | 3 | PS50191 | |
| Domain | CRAL-TRIO_dom | 2.21e-04 | 28 | 79 | 3 | IPR001251 | |
| Domain | F-box_dom | 2.87e-04 | 75 | 79 | 4 | IPR001810 | |
| Domain | VPS13_N | 4.87e-04 | 8 | 79 | 2 | IPR026854 | |
| Domain | Chorein_N | 4.87e-04 | 8 | 79 | 2 | PF12624 | |
| Domain | WD_REPEATS_1 | 1.15e-03 | 278 | 79 | 6 | PS00678 | |
| Domain | WD_REPEATS_2 | 1.18e-03 | 279 | 79 | 6 | PS50082 | |
| Domain | WD_REPEATS_REGION | 1.18e-03 | 279 | 79 | 6 | PS50294 | |
| Domain | Dynein_HC_stalk | 1.56e-03 | 14 | 79 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.56e-03 | 14 | 79 | 2 | IPR013602 | |
| Domain | DHC_N2 | 1.56e-03 | 14 | 79 | 2 | PF08393 | |
| Domain | MT | 1.56e-03 | 14 | 79 | 2 | PF12777 | |
| Domain | ATPase_dyneun-rel_AAA | 1.56e-03 | 14 | 79 | 2 | IPR011704 | |
| Domain | AAA_5 | 1.56e-03 | 14 | 79 | 2 | PF07728 | |
| Domain | Acyltransferase | 2.04e-03 | 16 | 79 | 2 | PF01553 | |
| Domain | PlsC | 2.31e-03 | 17 | 79 | 2 | SM00563 | |
| Domain | Plipid/glycerol_acylTrfase | 2.31e-03 | 17 | 79 | 2 | IPR002123 | |
| Domain | - | 2.86e-03 | 333 | 79 | 6 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 2.95e-03 | 335 | 79 | 6 | IPR015943 | |
| Domain | RNaseH-like_dom | 3.12e-03 | 69 | 79 | 3 | IPR012337 | |
| Domain | PROTEIN_KINASE_ATP | 3.27e-03 | 459 | 79 | 7 | PS00107 | |
| Domain | CRAL_TRIO | 3.52e-03 | 21 | 79 | 2 | PF00650 | |
| Domain | FBOX | 3.52e-03 | 72 | 79 | 3 | PS50181 | |
| Domain | - | 4.22e-03 | 23 | 79 | 2 | 3.40.525.10 | |
| Domain | Spectrin | 4.22e-03 | 23 | 79 | 2 | PF00435 | |
| Domain | Prot_kinase_dom | 4.62e-03 | 489 | 79 | 7 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 4.83e-03 | 493 | 79 | 7 | PS50011 | |
| Domain | G-protein_beta_WD-40_rep | 5.61e-03 | 85 | 79 | 3 | IPR020472 | |
| Domain | Spectrin_repeat | 6.66e-03 | 29 | 79 | 2 | IPR002017 | |
| Domain | Kinase-like_dom | 7.99e-03 | 542 | 79 | 7 | IPR011009 | |
| Domain | Spectrin/alpha-actinin | 8.07e-03 | 32 | 79 | 2 | IPR018159 | |
| Domain | SPEC | 8.07e-03 | 32 | 79 | 2 | SM00150 | |
| Pathway | BIOCARTA_RACCYCD_PATHWAY | 3.13e-06 | 26 | 56 | 4 | M14512 | |
| Pathway | BIOCARTA_RACCYCD_PATHWAY | 3.13e-06 | 26 | 56 | 4 | MM1423 | |
| Pathway | WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19 | 7.51e-05 | 21 | 56 | 3 | M40061 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 1.62e-04 | 27 | 56 | 3 | M47755 | |
| Pathway | WP_TLR4_SIGNALING_AND_TOLERANCE | 1.81e-04 | 28 | 56 | 3 | M39561 | |
| Pathway | REACTOME_SLC15A4_TASL_DEPENDENT_IRF5_ACTIVATION | 2.30e-04 | 6 | 56 | 2 | M48272 | |
| Pathway | REACTOME_SLC15A4_TASL_DEPENDENT_IRF5_ACTIVATION | 2.30e-04 | 6 | 56 | 2 | MM17244 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_CCNE_TO_CELL_CYCLE_G1_S | 2.30e-04 | 6 | 56 | 2 | M47489 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_VFLIP_TO_NFKB_SIGNALING_PATHWAY | 2.30e-04 | 6 | 56 | 2 | M47462 | |
| Pathway | REACTOME_DEATH_RECEPTOR_SIGNALING | 2.44e-04 | 142 | 56 | 5 | MM15431 | |
| Pathway | WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88 | 2.47e-04 | 31 | 56 | 3 | M39573 | |
| Pathway | WP_TOLLLIKE_RECEPTOR_SIGNALING | 2.98e-04 | 33 | 56 | 3 | MM15940 | |
| Pathway | REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA | 2.98e-04 | 33 | 56 | 3 | MM14666 | |
| Pathway | WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION | 2.98e-04 | 33 | 56 | 3 | M39909 | |
| Pathway | REACTOME_IKBA_VARIANT_LEADS_TO_EDA_ID | 3.21e-04 | 7 | 56 | 2 | M27463 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_VFLIP_TO_TNF_NFKB_SIGNALING_PATHWAY | 3.21e-04 | 7 | 56 | 2 | M47464 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E7_TO_P27_CELL_CYCLE_G1_S | 3.21e-04 | 7 | 56 | 2 | M47527 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 3.40e-04 | 84 | 56 | 4 | M3228 | |
| Pathway | REACTOME_DEATH_RECEPTOR_SIGNALING | 3.55e-04 | 154 | 56 | 5 | M27697 | |
| Pathway | KEGG_PROSTATE_CANCER | 4.24e-04 | 89 | 56 | 4 | M13191 | |
| Pathway | WP_CANONICAL_NFKB_PATHWAY | 4.27e-04 | 8 | 56 | 2 | M39783 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_P21_CELL_CYCLE_G1_S_N00498 | 4.27e-04 | 8 | 56 | 2 | M47585 | |
| Pathway | KEGG_MEDICUS_VARIANT_LOSS_OF_CDKN1B_TO_P27_CELL_CYCLE_G1_S | 4.27e-04 | 8 | 56 | 2 | M47429 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_K15_TO_TNF_NFKB_SIGNALING_PATHWAY | 4.27e-04 | 8 | 56 | 2 | M47463 | |
| Pathway | REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS | 4.90e-04 | 39 | 56 | 3 | M3871 | |
| Pathway | BIOCARTA_FBW7_PATHWAY | 5.48e-04 | 9 | 56 | 2 | MM1568 | |
| Pathway | BIOCARTA_FBW7_PATHWAY | 5.48e-04 | 9 | 56 | 2 | M22053 | |
| Pathway | WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT | 5.48e-04 | 9 | 56 | 2 | M39757 | |
| Pathway | WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD | 5.48e-04 | 9 | 56 | 2 | M39509 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_P21_CELL_CYCLE_G1_S_N00497 | 5.48e-04 | 9 | 56 | 2 | M47584 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_P27_CELL_CYCLE_G1_S_N00482 | 5.48e-04 | 9 | 56 | 2 | M47578 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOD_NFKB_SIGNALING_PATHWAY | 5.48e-04 | 9 | 56 | 2 | M47652 | |
| Pathway | WP_NODLIKE_RECEPTOR_NLR_SIGNALING | 5.48e-04 | 9 | 56 | 2 | M39494 | |
| Pathway | WP_NODLIKE_RECEPTOR_NLR_SIGNALING_PATHWAY | 5.48e-04 | 9 | 56 | 2 | MM15889 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPE_E2_TO_NOD_NFKB_SIGNALING_PATHWAY | 5.48e-04 | 9 | 56 | 2 | M47734 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 5.66e-04 | 96 | 56 | 4 | M39834 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 6.55e-04 | 43 | 56 | 3 | M47669 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LIGHT_HVEM_NFKB_SIGNALING_PATHWAY | 6.83e-04 | 10 | 56 | 2 | M47599 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_NFKB_SIGNALING_PATHWAY | 6.83e-04 | 10 | 56 | 2 | M47601 | |
| Pathway | BIOCARTA_SKP2E2F_PATHWAY | 6.83e-04 | 10 | 56 | 2 | MM1384 | |
| Pathway | BIOCARTA_SKP2E2F_PATHWAY | 6.83e-04 | 10 | 56 | 2 | M6031 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 7.49e-04 | 45 | 56 | 3 | M47670 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MDM2_P21_CELL_CYCLE_G1_S_N00536 | 8.33e-04 | 11 | 56 | 2 | M47591 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_P27_CELL_CYCLE_G1_S_N00264 | 8.33e-04 | 11 | 56 | 2 | M47492 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_EBV_LMP1_TO_NFKB_SIGNALING_PATHWAY | 8.33e-04 | 11 | 56 | 2 | M47493 | |
| Pathway | REACTOME_REGULATION_OF_TNFR1_SIGNALING | 8.51e-04 | 47 | 56 | 3 | MM15179 | |
| Pathway | WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ | 9.97e-04 | 12 | 56 | 2 | M39552 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HSV_GD_TO_HVEM_NFKB_SIGNALING_PATHWAY | 9.97e-04 | 12 | 56 | 2 | M47600 | |
| Pathway | BIOCARTA_P27_PATHWAY | 9.97e-04 | 12 | 56 | 2 | MM1472 | |
| Pathway | BIOCARTA_P27_PATHWAY | 1.18e-03 | 13 | 56 | 2 | M17977 | |
| Pathway | REACTOME_MAP3K8_TPL2_DEPENDENT_MAPK1_3_ACTIVATION | 1.18e-03 | 13 | 56 | 2 | MM15280 | |
| Pathway | REACTOME_ZBP1_DAI_MEDIATED_INDUCTION_OF_TYPE_I_IFNS | 1.18e-03 | 13 | 56 | 2 | MM14616 | |
| Pathway | WP_OSTEOPONTIN_SIGNALING | 1.18e-03 | 13 | 56 | 2 | M39603 | |
| Pathway | REACTOME_NF_KB_ACTIVATION_THROUGH_FADD_RIP_1_PATHWAY_MEDIATED_BY_CASPASE_8_AND_10 | 1.18e-03 | 13 | 56 | 2 | M957 | |
| Pathway | WP_CARDIAC_HYPERTROPHIC_RESPONSE | 1.35e-03 | 55 | 56 | 3 | M39685 | |
| Pathway | KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY | 1.35e-03 | 55 | 56 | 3 | M11844 | |
| Pathway | BIOCARTA_CD40_PATHWAY | 1.37e-03 | 14 | 56 | 2 | MM1362 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_NEF_TO_TNF_NFKB_SIGNALING_PATHWAY | 1.37e-03 | 14 | 56 | 2 | M47567 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P27_CELL_CYCLE_G1_S | 1.37e-03 | 14 | 56 | 2 | M47427 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGFR_PI3K_NFKB_SIGNALING_PATHWAY | 1.37e-03 | 14 | 56 | 2 | M47467 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_NFKB_SIGNALING_PATHWAY | 1.37e-03 | 14 | 56 | 2 | M47536 | |
| Pathway | REACTOME_IRAK1_RECRUITS_IKK_COMPLEX | 1.37e-03 | 14 | 56 | 2 | M935 | |
| Pathway | REACTOME_TRAF6_MEDIATED_NF_KB_ACTIVATION | 1.37e-03 | 14 | 56 | 2 | MM15641 | |
| Pathway | REACTOME_TNF_SIGNALING | 1.42e-03 | 56 | 56 | 3 | MM15453 | |
| Pathway | REACTOME_TNF_SIGNALING | 1.49e-03 | 57 | 56 | 3 | M27713 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 1.57e-03 | 15 | 56 | 2 | MM1339 | |
| Pathway | BIOCARTA_CD40_PATHWAY | 1.57e-03 | 15 | 56 | 2 | M16697 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_TNF_NFKB_SIGNALING_PATHWAY | 1.57e-03 | 15 | 56 | 2 | M47566 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_MYC_TO_P27_CELL_CYCLE_G1_S | 1.57e-03 | 15 | 56 | 2 | M47428 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_NFKB_SIGNALING_PATHWAY | 1.57e-03 | 15 | 56 | 2 | M47816 | |
| Pathway | BIOCARTA_P53_PATHWAY | 1.57e-03 | 15 | 56 | 2 | MM1451 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 1.57e-03 | 15 | 56 | 2 | M10183 | |
| Pathway | REACTOME_IRAK1_RECRUITS_IKK_COMPLEX | 1.57e-03 | 15 | 56 | 2 | MM15645 | |
| Pathway | WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY | 1.73e-03 | 60 | 56 | 3 | M39583 | |
| Pathway | WP_ID_SIGNALING | 1.79e-03 | 16 | 56 | 2 | M39359 | |
| Pathway | REACTOME_MAP3K8_TPL2_DEPENDENT_MAPK1_3_ACTIVATION | 1.79e-03 | 16 | 56 | 2 | M27567 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TNF_NFKB_SIGNALING_PATHWAY | 1.79e-03 | 16 | 56 | 2 | M47453 | |
| Pathway | BIOCARTA_P53_PATHWAY | 1.79e-03 | 16 | 56 | 2 | M14863 | |
| Pathway | WP_G1_TO_S_CELL_CYCLE_CONTROL | 1.82e-03 | 61 | 56 | 3 | MM15912 | |
| Pathway | BIOCARTA_TNFR2_PATHWAY | 2.03e-03 | 17 | 56 | 2 | M10082 | |
| Pathway | BIOCARTA_TNFR2_PATHWAY | 2.03e-03 | 17 | 56 | 2 | MM1517 | |
| Pathway | REACTOME_REGULATION_OF_NF_KAPPA_B_SIGNALING | 2.03e-03 | 17 | 56 | 2 | MM15702 | |
| Pathway | REACTOME_ABERRANT_REGULATION_OF_MITOTIC_G1_S_TRANSITION_IN_CANCER_DUE_TO_RB1_DEFECTS | 2.03e-03 | 17 | 56 | 2 | M38998 | |
| Pathway | REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_ZBP1 | 2.03e-03 | 17 | 56 | 2 | M583 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR5_NFKB_SIGNALING_PATHWAY | 2.03e-03 | 17 | 56 | 2 | M47912 | |
| Pathway | WP_MEASLES_VIRUS_INFECTION | 2.06e-03 | 136 | 56 | 4 | M42547 | |
| Pathway | WP_G1_TO_S_CELL_CYCLE_CONTROL | 2.08e-03 | 64 | 56 | 3 | M39627 | |
| Pathway | BIOCARTA_41BB_PATHWAY | 2.28e-03 | 18 | 56 | 2 | M2064 | |
| Pathway | BIOCARTA_41BB_PATHWAY | 2.28e-03 | 18 | 56 | 2 | MM1511 | |
| Pathway | REACTOME_REGULATION_OF_NF_KAPPA_B_SIGNALING | 2.28e-03 | 18 | 56 | 2 | M45023 | |
| Pathway | WP_RAC1PAK1P38MMP2_PATHWAY | 2.48e-03 | 68 | 56 | 3 | M39456 | |
| Pathway | REACTOME_TICAM1_RIP1_MEDIATED_IKK_COMPLEX_RECRUITMENT | 2.54e-03 | 19 | 56 | 2 | M27020 | |
| Pathway | BIOCARTA_TID_PATHWAY | 2.54e-03 | 19 | 56 | 2 | M9546 | |
| Pathway | WP_UROTENSINIIMEDIATED_SIGNALING | 2.58e-03 | 69 | 56 | 3 | M48052 | |
| Pathway | REACTOME_S_PHASE | 2.67e-03 | 146 | 56 | 4 | MM15378 | |
| Pathway | KEGG_PANCREATIC_CANCER | 2.69e-03 | 70 | 56 | 3 | M9726 | |
| Pathway | KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY | 2.80e-03 | 71 | 56 | 3 | M15913 | |
| Pathway | REACTOME_RHOG_GTPASE_CYCLE | 2.80e-03 | 71 | 56 | 3 | MM15604 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR1_2_4_NFKB_SIGNALING_PATHWAY | 2.81e-03 | 20 | 56 | 2 | M47563 | |
| Pathway | KEGG_CHRONIC_MYELOID_LEUKEMIA | 3.03e-03 | 73 | 56 | 3 | M321 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | CCNE1 DIP2A KMT2D KANSL1 ZBED4 KALRN PHF12 POLE CPSF1 DEPDC5 MED13L MCF2L ZC3H7B SH2B2 GPAT4 REXO1 RIC1 | 8.59e-10 | 1105 | 83 | 17 | 35748872 |
| Pubmed | 1.31e-07 | 5 | 83 | 3 | 16393995 | ||
| Pubmed | 2.61e-07 | 6 | 83 | 3 | 9914500 | ||
| Pubmed | 2.61e-07 | 6 | 83 | 3 | 11959143 | ||
| Pubmed | Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. | 2.61e-07 | 6 | 83 | 3 | 16177806 | |
| Pubmed | 4.56e-07 | 7 | 83 | 3 | 12133833 | ||
| Pubmed | 7.28e-07 | 8 | 83 | 3 | 17568778 | ||
| Pubmed | 7.28e-07 | 8 | 83 | 3 | 18299349 | ||
| Pubmed | Competition between TRAF2 and TRAF6 regulates NF-kappaB activation in human B lymphocytes. | 1.09e-06 | 9 | 83 | 3 | 20449947 | |
| Pubmed | 1.09e-06 | 9 | 83 | 3 | 15489227 | ||
| Pubmed | IκB kinase ε phosphorylates TRAF2 to promote mammary epithelial cell transformation. | 2.13e-06 | 11 | 83 | 3 | 23007157 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 2.98e-06 | 497 | 83 | 9 | 36774506 | |
| Pubmed | 4.68e-06 | 14 | 83 | 3 | 9373155 | ||
| Pubmed | 4.97e-06 | 47 | 83 | 4 | 8812413 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 29993183 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 10232975 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 9813230 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 9453249 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 22833419 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 18163512 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 33414459 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 32699255 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 20195534 | ||
| Pubmed | FBXW10 promotes hepatocarcinogenesis in male patients and mice. | 5.63e-06 | 2 | 83 | 2 | 31400758 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 36528060 | ||
| Pubmed | IKKα contributes to UVB-induced VEGF expression by regulating AP-1 transactivation. | 5.63e-06 | 2 | 83 | 2 | 22169952 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 14585846 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 26371187 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 9346241 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 20448200 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 37450367 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 15897281 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 15531584 | ||
| Pubmed | I-kappa B kinases alpha and beta have distinct roles in regulating murine T cell function. | 5.63e-06 | 2 | 83 | 2 | 11937522 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 21490922 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 24155403 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 33226912 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 31060523 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 30523059 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 21248029 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 11815618 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 33260006 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 9520401 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 18000063 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 30760575 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 20181984 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 22891964 | ||
| Pubmed | IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. | 5.63e-06 | 2 | 83 | 2 | 9346484 | |
| Pubmed | 7.86e-06 | 300 | 83 | 7 | 10591208 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 35073341 | ||
| Pubmed | Withaferin A disrupts ubiquitin-based NEMO reorganization induced by canonical NF-κB signaling. | 1.69e-05 | 3 | 83 | 2 | 25304104 | |
| Pubmed | IKKalpha and IKKbeta regulation of DNA damage-induced cleavage of huntingtin. | 1.69e-05 | 3 | 83 | 2 | 19488402 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 21537326 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 17145747 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 20671747 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 23349802 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 17000764 | ||
| Pubmed | Inhibition of IkappaB kinase by vaccinia virus virulence factor B14. | 1.69e-05 | 3 | 83 | 2 | 18266467 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 34724040 | ||
| Pubmed | Signal processing by its coil zipper domain activates IKK gamma. | 1.69e-05 | 3 | 83 | 2 | 18216269 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 11359906 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 11594795 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 11527961 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 30988283 | ||
| Pubmed | NEMO binding domain of IKK-2 encompasses amino acids 735-745. | 1.69e-05 | 3 | 83 | 2 | 16583354 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 12459277 | ||
| Pubmed | The IkappaB kinase complex: master regulator of NF-kappaB signaling. | 1.69e-05 | 3 | 83 | 2 | 18626576 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 38775480 | ||
| Pubmed | HIV-1 Vpr protein activates the NF-κB pathway to promote G2/M cell cycle arrest. | 1.69e-05 | 3 | 83 | 2 | 26676942 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 19270264 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 20145131 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 10593965 | ||
| Pubmed | Inhibitor of kappaB kinase is required to activate a subset of interferon gamma-stimulated genes. | 1.69e-05 | 3 | 83 | 2 | 15148408 | |
| Pubmed | A role for the NF-κB pathway in cell protection from complement-dependent cytotoxicity. | 1.69e-05 | 3 | 83 | 2 | 22685314 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 18704119 | ||
| Pubmed | IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex. | 1.69e-05 | 3 | 83 | 2 | 9751060 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 21784860 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 28499869 | ||
| Pubmed | Canonical, Non-Canonical and Atypical Pathways of Nuclear Factor кb Activation in Preeclampsia. | 1.69e-05 | 3 | 83 | 2 | 32759710 | |
| Pubmed | Does the expression of cyclin E, pRb, and p21 correlate with prognosis in gastric adenocarcinoma? | 1.69e-05 | 3 | 83 | 2 | 19058005 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 12612076 | ||
| Pubmed | Mixed-lineage kinase 3 delivers CD3/CD28-derived signals into the IkappaB kinase complex. | 1.69e-05 | 3 | 83 | 2 | 10713178 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 9632806 | ||
| Pubmed | miR-339-5p inhibits alcohol-induced brain inflammation through regulating NF-κB pathway. | 1.69e-05 | 3 | 83 | 2 | 25172655 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 15709169 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 22301546 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 24345681 | ||
| Pubmed | Structure of a NEMO/IKK-associating domain reveals architecture of the interaction site. | 1.69e-05 | 3 | 83 | 2 | 18462684 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 12221085 | ||
| Pubmed | The inflammatory kinase IKKα phosphorylates and stabilizes c-Myc and enhances its activity. | 1.69e-05 | 3 | 83 | 2 | 33461590 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 10968790 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 11297557 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 21519154 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 15856023 | ||
| Pubmed | IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. | 1.69e-05 | 3 | 83 | 2 | 10521409 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 12096344 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 11839743 | ||
| Pubmed | Protein kinase C-associated kinase regulates NF-κB activation through inducing IKK activation. | 1.69e-05 | 3 | 83 | 2 | 25096806 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 20051109 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 12054687 | ||
| Cytoband | 2p24 | 2.11e-04 | 12 | 83 | 2 | 2p24 | |
| GeneFamily | Dyneins, axonemal | 1.64e-07 | 17 | 54 | 4 | 536 | |
| GeneFamily | Glycerol-3-phosphate acyltransferases | 5.23e-05 | 4 | 54 | 2 | 1035 | |
| GeneFamily | UPF1 like RNA helicases | 4.73e-04 | 11 | 54 | 2 | 1169 | |
| GeneFamily | WD repeat domain containing|F-box and WD repeat domain containing | 4.73e-04 | 11 | 54 | 2 | 559 | |
| GeneFamily | 1-acylglycerol-3-phosphate O-acyltransferases | 4.73e-04 | 11 | 54 | 2 | 46 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.71e-06 | 180 | 83 | 7 | M8239 | |
| Coexpression | GILMORE_CORE_NFKB_PATHWAY | 8.56e-06 | 13 | 83 | 3 | M8804 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-1|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.65e-06 | 193 | 83 | 6 | c2673d86f7d7b849788036032a93a6d136a70040 | |
| Disease | autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology) | 2.34e-05 | 3 | 83 | 2 | DOID:0111611 (implicated_via_orthology) | |
| Disease | liver cancer (is_implicated_in) | 7.77e-05 | 5 | 83 | 2 | DOID:3571 (is_implicated_in) | |
| Disease | Disease Exacerbation | 1.05e-04 | 165 | 83 | 5 | C0235874 | |
| Disease | muscular atrophy (implicated_via_orthology) | 1.63e-04 | 7 | 83 | 2 | DOID:767 (implicated_via_orthology) | |
| Disease | prostate cancer (is_implicated_in) | 3.39e-04 | 117 | 83 | 4 | DOID:10283 (is_implicated_in) | |
| Disease | Heschl's gyrus morphology measurement | 4.54e-04 | 53 | 83 | 3 | EFO_0005852 | |
| Disease | Malignant neoplasm of skin | 6.23e-04 | 59 | 83 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 6.23e-04 | 59 | 83 | 3 | C0037286 | |
| Disease | Bladder Neoplasm | 6.67e-04 | 140 | 83 | 4 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 6.85e-04 | 141 | 83 | 4 | C0005684 | |
| Disease | JT interval | 6.86e-04 | 248 | 83 | 5 | EFO_0007885 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 8.02e-04 | 15 | 83 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 8.02e-04 | 15 | 83 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 8.02e-04 | 15 | 83 | 2 | C0154091 | |
| Disease | Benign neoplasm of stomach | 1.03e-03 | 17 | 83 | 2 | C0153943 | |
| Disease | Eye Abnormalities | 1.03e-03 | 17 | 83 | 2 | C0015393 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 1.03e-03 | 17 | 83 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 1.03e-03 | 17 | 83 | 2 | C0154060 | |
| Disease | Carcinoma of bladder | 1.16e-03 | 18 | 83 | 2 | C0699885 | |
| Disease | Stomach Neoplasms | 1.53e-03 | 297 | 83 | 5 | C0038356 | |
| Disease | Stomach Carcinoma | 1.59e-03 | 21 | 83 | 2 | C0699791 | |
| Disease | Malignant neoplasm of stomach | 1.60e-03 | 300 | 83 | 5 | C0024623 | |
| Disease | lung squamous cell carcinoma (is_implicated_in) | 2.07e-03 | 24 | 83 | 2 | DOID:3907 (is_implicated_in) | |
| Disease | Squamous cell carcinoma of esophagus | 2.47e-03 | 95 | 83 | 3 | C0279626 | |
| Disease | Sezary Syndrome | 2.62e-03 | 27 | 83 | 2 | C0036920 | |
| Disease | Alzheimer disease, APOE carrier status | 2.69e-03 | 98 | 83 | 3 | EFO_0007659, MONDO_0004975 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KRCWDVHQRLNRAME | 71 | Q8N350 | |
| CHMDTIDWRDIVRDR | 156 | P21860 | |
| AEAIKEHERWLAMCI | 401 | Q400G9 | |
| HCVNREDVRLAWIMT | 1046 | Q8IWK6 | |
| CERGLVKVWHIAMAQ | 551 | Q5XX13 | |
| WLMEVCEVYKLHRET | 151 | P24864 | |
| VREFWRLLAICHTVM | 561 | O60423 | |
| TAERRHTICSLDWRM | 191 | Q9NUG4 | |
| ERCEHRIMESLAWLS | 551 | P06400 | |
| WKCQNMLRSHVRELL | 506 | Q29RF7 | |
| ALEQGKWDLCRHMIR | 966 | Q4ADV7 | |
| CLMWRVGNLRKSHIV | 201 | P48050 | |
| CERGLVKVWHIAMAQ | 551 | O95170 | |
| RLVTFWTSCLEKMHA | 1586 | O75140 | |
| LLMERASTRDRWLHK | 81 | A6NJV1 | |
| MRAVLTWRDKAEHCI | 1 | Q9HBG6 | |
| MVHRVWKECILNRTQ | 376 | Q71F56 | |
| VWRALCMTLVKRRDA | 236 | Q9BXT6 | |
| DVKSMWDDIRLHLRR | 156 | Q8IV33 | |
| ERWCLEIQIMRRLTH | 56 | O14920 | |
| STKNRERWCHEIQIM | 51 | O15111 | |
| MAASRWARKAVVLLC | 1 | Q14696 | |
| RGLHWVMEVLQATCR | 441 | Q14164 | |
| RIELQEWEHVTCMKT | 1091 | Q10570 | |
| RERCMKAWLLEEESL | 426 | Q76G19 | |
| WKPHCMTVRAVCRRE | 76 | Q5FWF7 | |
| CSWHTLRMRKRAEVE | 2401 | O60229 | |
| NATITMCRMRARHWK | 766 | Q6ZR08 | |
| MCRMRARHWKQISEI | 771 | Q6ZR08 | |
| QTVDRHWRDIMKFCA | 936 | Q6ZR08 | |
| HAKCEEMERARWLWT | 921 | Q7Z3B3 | |
| RRWEHLIFMKLCSSV | 826 | Q86UK5 | |
| QCIHMDCLRWVKRDS | 401 | Q07864 | |
| HQLMLDCWQKERAER | 866 | Q15375 | |
| HRAKDWCEELACRMV | 796 | A2RRP1 | |
| DVLERVKFSCMAWTH | 166 | P48147 | |
| DWLREVERSMKASVH | 1396 | Q9P2D7 | |
| IMEVAKERSRARHAW | 166 | Q96DF8 | |
| HMMLSQRWAVKERDC | 416 | Q05DH4 | |
| ACHREVRLLKELWDM | 1271 | Q9UFH2 | |
| AMVKACPHVWFERSE | 261 | Q53EU6 | |
| MVKACPHVWFERSEV | 281 | Q86UL3 | |
| ARLCEDVERKMAREW | 346 | A8MYV0 | |
| DLRWLVGEMHCQKIA | 616 | P10643 | |
| RWNSDECLRAVLKLM | 486 | P36894 | |
| KRCNLHLVDIWNMIE | 46 | O60941 | |
| SHWITMRVALLCEKN | 3491 | Q0VDD8 | |
| NMCKRDRVSWHLIGL | 636 | Q6MZM0 | |
| HRRLETSMKWCDEGI | 461 | O15068 | |
| WRHRNVESLCVMETA | 496 | Q9UKA1 | |
| ARAALVKSRDMHWSL | 601 | Q14689 | |
| IDKAREIMCQSLTWR | 291 | Q92503 | |
| HKECKNMRWDRLSIL | 341 | Q9NTJ5 | |
| HIVRCLGVNWMKEDA | 706 | B7ZC32 | |
| KVVSCMEQLTRSHWE | 281 | Q96BN6 | |
| CMKVHQDSARRDRWS | 41 | Q6ZUA9 | |
| LRRSCLRALWHKVMF | 106 | P30711 | |
| RVRLSRHKLERWCHM | 361 | Q92541 | |
| DAGACMHLVIWKVRE | 1201 | Q8N1G1 | |
| WMITECRDKKHQRTL | 186 | Q9Y2R9 | |
| AREKRGEHLSWLCMF | 271 | Q496J9 | |
| KNWDHILCAIERMII | 461 | Q9ULS5 | |
| LMRRDQVLKVCANHW | 1091 | P0DJD1 | |
| LCHLEEAKRWMEVCL | 41 | Q13576 | |
| EWMCHRCTVRRKKRE | 96 | Q96QT6 | |
| HCFMVILDRLGSKVW | 291 | Q7Z333 | |
| HKETRCTLMRRGDNW | 446 | Q86YJ6 | |
| CAWNRKALLHRDTML | 266 | Q5TEU4 | |
| LRDCNVAIRWLMLHT | 366 | Q12768 | |
| ERLSHMMERKAWCSQ | 16 | Q3ZCX4 | |
| LAKVSHMTSDRRQWC | 216 | O60499 | |
| MARWIKELFCHNERV | 291 | Q9UG56 | |
| MDKTVRLWHISRREC | 626 | Q5JSH3 | |
| ELLERKAVAWMRAHA | 746 | O00534 | |
| WKEELHRSREVRCML | 2611 | Q709C8 | |
| SLCVVDGVRDMWHRR | 141 | O14492 | |
| CADKLQRLEESMHRW | 96 | Q86XT2 | |
| WLTCFLRHERIHMRE | 571 | Q9Y2A4 | |
| LKFIRKMTSRHWCAV | 471 | Q13395 | |
| WHVRIAIRMELLECV | 206 | O15537 | |
| MWHIVDKCTELLREG | 136 | O15209 | |
| RHCWTKERRVLLVMS | 721 | Q9UGR2 | |
| CLIRHMWRAHRAIVL | 326 | O75132 | |
| REQRKRCTWDFMLHR | 331 | Q5THJ4 | |
| EEDLLIQCRHCERWM | 1516 | O14686 | |
| RSHTVWERMSVKLCF | 161 | P54296 |